Similar companies
Company | Revenue | |
---|---|---|
BARKBARK |
126M 8.5% | |
PetMedsPETS |
60M 12.3% |
Income Statement (USD)
Q3 '24 | QoQ | |
---|---|---|
Revenue | 2.39B | 1.1% |
Gross Profit | 1.08B | 2% |
Cost of Revenue | 1.31B | 0.5% |
Operating expense | 774M | 3.9% |
Net Income | 682M | 9.3% |
EBITDA | 963M | 9.3% |
Balance Sheet (USD)
Q3 '24 | QoQ | |
---|---|---|
Total Assets | 14.4B | 1.4% |
Total Liabilities | 9.12B | 0.9% |
Total Equity | 5.23B | 5.4% |
Shares Outstanding | 452M | 0.5% |
Cash Flow (USD)
Q3 '24 | QoQ | |
---|---|---|
Cash from operations | 951M | 89.4% |
Cash from investing | -178M | 34.8% |
Cash from financing | -628M | 17.7% |
EPS
Financial Highlights for Zoetis in Q3 '24
Zoetis reported a revenue of 2.39B, which is a 1.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 1.08B, marking a 2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.31B, a 0.5% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 774M, showing a -3.9% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 682M, showing a 9.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 963M, showing a 9.3% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Zoetis with growth in revenue, gross profit, and net income.